Cointime

Home / Entrada Therapeutics / investors

Entrada Therapeutics

company

Investors

Number of Lead Investors
Number of Investors
3
14
Entrada Therapeutics is funded by 14 investors. Wellington Management and 5AM Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Wellington Management Yes Series B
5AM Ventures - Series B
Agent Capital - Series B
CureDuchenne Ventures - Series B
Goldman Sachs - Series B
Greenspring Associates - Series B
Moore Strategic Ventures - Series B
MPM Capital - Series B
MRL Ventures Fund - Series B
Point72 Ventures - Series B
Qatar Investment Authority - Series B
Redmile Group - Series B
Roche Venture Fund - Series B
TCG Crossover - Series B
Cointime
İçerikler
Şirket.